Abstract:Background and Objectives: Damage to normal bone tissue following therapeutic irradiation (IR) represents a significant concern, as IR-induced bone microenvironment disruption can cause bone loss and create a more favorable environment for tumor metastases. The aim of the present study was to explore the cellular regulatory mechanism of IR-induced bone microenvironment disruption to effectively prevent radiotherapy-associated adverse effects in the future. Materials and Methods: In this study, a mouse model of local IR was established via local irradiation of the left hind limb of BALB/c mice with 12 Gy X-rays, and an in vitro osteocyte (OCY) model was established by exposing osteocyte-like MLO-Y4 cells to 2, 4, and 8 Gy irradiation to analyze multicellular biological injuries and cellular senescence. Small interfering RNA (siRNA) transfection at the cellular level and a selective antagonist intervention C-176 at the animal level were used to explore the potential role of the stimulator of interferon genes (STING) on IR-induced bone microenvironment disruption. Results: The results showed that 12 Gy local IR induces multicellular dysfunction, manifested as ascension of OCYs exfoliation, activation of osteoclastogenesis, degeneration of osteogenesis and fate conversion of adipogenesis, as well as cellular senescence and altered senescence-associated secretory phenotype (SASP) secretion. Furthermore, the expression of STING was significantly elevated, both in the primary OCYs harvested from locally irradiated mice and in vitro irradiated MLO-Y4 cells, accompanied by the markedly upregulated levels of phosphorylated TANK-binding kinase 1 (P-TBK1), RANKL and sclerostin (SOST). STING-siRNA transfection in vitro restored IR-induced upregulated protein expression of P-TBK1 and RANKL, as well as the mRNA expression levels of inflammatory cytokines, such as IL-1α, IL-6 and NF-κB, accompanied by the alleviation of excessive osteoclastogenesis. Finally, administration of the STING inhibitor C-176 mitigated IR-induced activation of osteoclastogenesis and restraint of osteogenesis, ameliorating the IR-induced biological damage of OCYs, consistent with the inhibition of P-TBK1, RANKL and SOST. Conclusions: The STING-P-TBK1 signaling pathway plays a crucial role in the regulation of the secretion of inflammatory cytokines and osteoclastogenesis potential in IR-induced bone microenvironment disruption. The selective STING antagonist can be used to intervene to block the STING pathway and, thereby, repair IR-induced multicellular biological damage and mitigate the imbalance between osteoclastogenesis and osteoblastgenesis.

Blockade of USP14 Potentiates Type I Interferon Signaling and Radiation-Induced Antitumor Immunity Via Preventing IRF3 Deubiquitination.

IRF1 Regulates the Progression of Colorectal Cancer Via Interferon‑induced Proteins.

Abstract SY39-03: Radiation-mediated DNA Sensing Pathway for Immunity and Tumor Regression

Radiation-Mediated Dna Sensing Pathway For Immunity And Tumor Regression

STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.

Deubiquitinase USP4 Suppresses Antitumor Immunity by Inhibiting IRF3 Activation and Tumor Cell-Intrinsic Interferon Response in Colorectal Cancer

HO-1 impairs the efficacy of radiotherapy by redistributing cGAS and STING in tumors

Non-canonical NF-κB Antagonizes STING Sensor-Mediated DNA Sensing in Radiotherapy.

Host STING-dependent MDSC mobilization drives extrinsic radiation resistance

USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer

STING Agonist‐Loaded Nanoparticles Promotes Positive Regulation of Type I Interferon‐Dependent Radioimmunotherapy in Rectal Cancer

Targeting the dendritic cell-secreted immunoregulatory cytokine CCL22 alleviates radioresistance

Radiation Induces Bone Microenvironment Disruption by Activating the STING-TBK1 Pathway

YTHDF1 loss in dendritic cells potentiates radiation-induced antitumor immunity via STING-dependent type I IFN production

Metabolic reprograming mediated by tumor cell-intrinsic type I IFN signaling is required for CD47-SIRPα blockade efficacy

DNA sensing and associated type 1 interferon signaling contributes to progression of radiation-induced liver injury

USP11 exacerbates radiation induced pneumonitis by activating endothelial cell inflammatory response via OTUD5-STING signaling

Deubiquitinase USP35 restrains STING-mediated interferon signaling in ovarian cancer

USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy

Combining radiation and the ATR inhibitor berzosertib activates STING signaling and enhances immunotherapy via inhibiting SHP1 function in colorectal cancer

Single High-Dose Irradiation-Induced Irhom2 Upregulation Promotes Macrophage Antitumor Activity Through Cgas/sting Signaling